Summit Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
4,538
-1,229
| -21% | -$499K | 0.04% | 304 |
|
|
2025
Q1 | $2.87M | Buy |
5,767
+606
| +12% | +$302K | 0.08% | 213 |
|
|
2024
Q4 | $2.69M | Sell |
5,161
-258
| -5% | -$134K | 0.09% | 172 |
|
|
2024
Q3 | $3.35M | Buy |
5,419
+705
| +15% | +$436K | 0.13% | 124 |
|
|
2024
Q2 | $2.61M | Buy |
4,714
+2,305
| +96% | +$1.28M | 0.12% | 122 |
|
|
2024
Q1 | $1.4M | Sell |
2,409
-405
| -14% | -$236K | 0.08% | 146 |
|
|
2023
Q4 | $1.49M | Buy |
2,814
+147
| +6% | +$78.1K | 0.1% | 129 |
|
|
2023
Q3 | $1.35M | Buy |
2,667
+303
| +13% | +$153K | 0.1% | 130 |
|
|
2023
Q2 | $1.23M | Buy |
2,364
+9
| +0.4% | +$4.7K | 0.09% | 132 |
|
|
2023
Q1 | $1.36M | Buy |
2,355
+65
| +3% | +$37.5K | 0.12% | 87 |
|
|
2022
Q4 | $1.26M | Sell |
2,290
-57
| -2% | -$31.4K | 0.12% | 94 |
|
|
2022
Q3 | $1.19M | Buy |
2,347
+435
| +23% | +$221K | 0.11% | 89 |
|
|
2022
Q2 | $1.04M | Buy |
1,912
+25
| +1% | +$13.6K | 0.1% | 96 |
|
|
2022
Q1 | $1.12M | Buy |
1,887
+137
| +8% | +$81K | 0.09% | 107 |
|
|
2021
Q4 | $1.17M | Buy |
1,750
+480
| +38% | +$320K | 0.09% | 96 |
|
|
2021
Q3 | $726K | Buy |
1,270
+619
| +95% | +$354K | 0.06% | 106 |
|
|
2021
Q2 | $329K | Buy |
+651
| New | +$329K | 0.03% | 120 |
|